Table 1.
Home (n = 305) | Clinic (n = 98) | p value | |
---|---|---|---|
Mean age (SD) | 25.1 (5.4) | 24.7 (5.2) | 0.48 |
Race/Ethnicity | |||
Black | 83 (27.5) | 41 (42.3) | |
White | 196 (64.9) | 50 (51.5) | |
Other | 23 (7.6) | 6 (6.2) | 0.02 |
Education | |||
Less than high school diploma | 35 (11.5) | 8 (8.2) | |
High school diploma or GED | 56 (18.4) | 21 (21.4) | |
Some college | 118 (38.6) | 43 (43.9) | |
College or graduate degree | 96 (31.5) | 26 (26.5) | 0.53 |
Monthly individual income | |||
$0–800 | 92 (30.2) | 33 (33.7) | |
$801–1,600 | 75 (24.6) | 27 (27.6) | |
$1,601+ | 73 (23.9) | 21 (21.4) | |
Refused or missing | 65 (21.3) | 17 (17.3) | 0.72 |
Marital Status | |||
Never Married | 204 (66.9) | 69 (70.4) | |
Married/Living with a Partner | 85 (27.9) | 23 (23.5) | |
Separated/Divorced/Widowed | 16 (5.2) | 6 (6.1) | 0.68 |
Contraceptive Method | |||
LARC (IUC or Implanon) | 199 (65.3) | 65 (66.3) | |
DMPA | 8 (2.6) | 4 (4.1) | |
Short-term refillable contraceptive (OC, patch, vaginal ring) | 97 (31.8) | 29 (29.6) | |
Barrier (Diaphragm, condom) | 1 (0.3) | 0 (0) | 0.75† |
Obtained health care in the last 12 months | 271 (88.9) | 88 (89.8) | 0.79 |
No health insurance | 104 (35.4) | 38 (39.6) | 0.46 |
History of STI* | 78 (25.7) | 28 (28.6) | 0.58 |
STI** diagnosed at enrollment | 4 (1.5) | 4 (4.7) | 0.11† |
Mean number of lifetime male sexual partners (SD) | 8.6 (8.6) | 10.5 (9.2) | 0.07 |
SD, standard deviation; GED, general education development test; LARC, long-acting reversible contraceptive; IUC, intrauterine contraceptive; DMPA, depomedroxyprogesterone; OC, oral contraceptive; STI, sexually transmitted infection. Data are n (%) unless otherwise indicated.
STI includes chlamydia, gonorrhea, trichomoniasis, syphilis, HIV, and genital herpes.
Includes chlamydia, gonorrhea, trichomoniasis, syphilis, and HIV, for which each participant is screened at baseline.
Fisher’s exact test.